Dublin, June 12, 2024 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibodies Market Report by Production Method, Source, Indication, End Use, and Region 2024-2032" report has been added to ResearchAndMarkets.com's offering.
The global monoclonal antibodies market size reached US$ 221.7 Billion in 2023. Looking forward, the market is projected to reach US$ 392.6 Billion by 2032, exhibiting a growth rate (CAGR) of 6.56% during 2023-2032.
At present, the growing prevalence of chronic diseases, such as cancer, heart disease, stroke, diabetes, and arthritis, represents one of the key factors driving the market. Besides this, leading manufacturers are extensively investing in research and development (R&D) activities to introduce enhanced mAb drugs for treating neurodegenerative diseases, such as Alzheimer's, Huntington's, Parkinson's, and Lewy body diseases. They are also focusing on various marketing strategies to expand their customer base, which is contributing to the growth of the market.
In addition, the increasing demand for humanized mAbs to treat various antigens, such as cancer cells, immunosuppression, and immunomodulatory molecules, are offering lucrative growth opportunities to industry investors. Apart from this, there is a rise in the demand for cost-efficient biosimilar mAbs to treat cancer across the globe. This, along with the burgeoning healthcare industry, is propelling the growth of the market.
Moreover, technological advancements in various genetic platforms, such as next-generation sequencing, is offering a positive market outlook. Additionally, there is an increase in the employment of advanced genetic engineering technology in mAbs production around the world. This, coupled with the rising awareness among the masses about the benefits of mAb therapy, is bolstering the market growth.
Competitive Landscape
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., Biogen Inc., F. Hoffmann-La Roche AG, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A. and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report
- What was the size of the global monoclonal antibodies market in 2023?
- What is the expected growth rate of the global monoclonal antibodies market during 2024-2032?
- What are the key factors driving the global monoclonal antibodies market?
- What has been the impact of COVID-19 on the global monoclonal antibodies market?
- What is the breakup of the global monoclonal antibodies market based on the production method?
- What is the breakup of the global monoclonal antibodies market based on the source?
- What is the breakup of the global monoclonal antibodies market based on the indication?
- What is the breakup of the global monoclonal antibodies market based on the end use?
- What are the key regions in the global monoclonal antibodies market?
- Who are the key players/companies in the global monoclonal antibodies market?
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 135 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value (USD) in 2023 | $221.7 Billion |
| Forecasted Market Value (USD) by 2032 | $392.6 Billion |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
Key Market Segmentation
This report provides an analysis of the key trends in each sub-segment of the global monoclonal antibodies market report, along with forecasts at the global, regional and country level from 2024-2032. The report has categorized the market based on production method, source, indication and end use.
Breakup by Production Method:
- In Vivo
- In Vitro
Breakup by Source:
- Murine
- Chimeric
- Humanized
- Human
Breakup by Indication:
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
Breakup by End Use:
- Hospitals
- Research Institutes
- Others
Companies Featured
- AbbVie Inc.
- Amgen Inc.
- Biogen Inc.
- F. Hoffmann-La Roche AG
- GSK plc
- Johnson & Johnson
- Merck KGaA
- Novartis AG
- Novo Nordisk A/S
- Pfizer Inc.
- Sanofi S.A.
- Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/r/9euc89
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
